PMV Pharmaceuticals, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
PMVP on Nasdaq
Location
One Research Way, Princeton, New Jersey

Insiders trading volume in the past year

PMV Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Interwest Partners X Lp 10%+ Owner $10 M Jul 13, 2021
Thilo Schroeder Director $2.46 M Oct 6, 2021
David H. Mack President and CEO, Director $1.11 M Jan 18, 2024
Euclidean Capital LLC 10%+ Owner $283 K Jun 11, 2021
Deepika Jalota Chief Development Officer $280 K -$27.2 K -8.85% Jan 18, 2024
Michael Carulli Chief Financial Officer $204 K Jan 18, 2024
Leila Alland Chief Medical Officer $102 K -$41.6 K -28.9% Sep 15, 2023
Winston Kung Coo, Cfo $23.6 K May 12, 2023
Peter A. Thompson Director, 10%+ Owner Jun 2, 2021
Arnold J. Levine Director Jun 6, 2024
Richard A. Heyman Director Jun 6, 2024
Orbimed Advisors Llc 10%+ Owner -$196 K Nov 22, 2023
Laurie Stelzer Director Jun 6, 2024
Carol Giltner Gallagher Director Jun 6, 2024
Kirsten Flowers Director Jun 6, 2024
Charles M. Baum Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for PMV Pharmaceuticals, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership